Seminars in Liver Disease

Papers
(The TQCC of Seminars in Liver Disease is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns76
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma69
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?67
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype48
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD44
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease40
HBV Biomarkers and Their Role in Guiding Treatment Decisions33
Genetic and Epigenetic Basis of Drug-Induced Liver Injury32
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease31
Hepatic Alveolar Echinococcosis28
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy28
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis24
Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis24
Wilson Disease: Novel Diagnostic and Therapeutic Approaches23
Role of YAP1 Signaling in Biliary Development, Repair, and Disease22
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems21
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury21
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies20
Physiomimetic In Vitro Human Models for Viral Infection in the Liver19
Mice Engrafted with Human Liver Cells19
Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective18
Diagnosis and Management of Early Stages of ALD15
Current and Evolving Indications for Simultaneous Liver Kidney Transplantation15
Interleukin-17 in Liver Disease Pathogenesis14
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity14
Circadian Regulation of Gene Expression and Metabolism in the Liver13
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination13
Role of Complement in Liver Diseases13
12
To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure11
Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure11
Liver Neurobiology: Regulation of Liver Functions by the Nervous System11
Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases11
This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol10
Erratum to: Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics10
10
Mesenchymal Stem Cell Transplantation in Liver Diseases10
Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future10
Novel Biomarkers of AKI in Cirrhosis10
Management of Portal vein Thrombosis in Cirrhosis9
9
Hepatitis Delta Infection: A Clinical Review8
The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease8
Hepatocellular Carcinoma Chemoprevention with Generic Agents8
Erratum to: Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis8
Artificial Intelligence in Hepatology: A Narrative Review8
Endoscopic Advances in Hepatology8
Erratum to: Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy8
0.037428140640259